Close

BIO Continues Partnership with NIH for Fifth “Innovation Zone” Exhibit

May 8 2019
“The theme for this year’s Convention sets a perfect tone for the Innovation Zone: It Starts with One. One idea, one vision, one sleepless night – that’s how breakthrough medicines and technologies are first imagined, and that’s why our partnership with NIH to sponsor companies focused on early stage R&D is so important,” said BIO’s President and CEO, Jim Greenwood.

Congress to EPA: Stop Undercutting Family Farms and Our Nation’s Renewable Fuel Future

May 7 2019
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood today expressed support for a U.S. House of Representatives letter, authored by Representatives Cindy Axne (D-Iowa) and Adrian Smith (R-Neb.), requesting U.S. Environmental Protection Agency (EPA) Administrator Andrew Wheeler immediately end the practice of granting small refinery exemptions under the Renewable Fuel Standard (RFS) for large or unqualified refiners. 

BIO Submits Comments Supportive of EPA Plan to Allow Year-Round Use of E15

Apr 29 2019
The Biotechnology Innovation Organization (BIO) today submitted comments supportive of the U.S. Environmental Protection Agency’s (EPA) “Proposed Rulemaking for Modifications to Fuel Regulations to Provide Flexibility for E15 and to Elements of the Renewable Identification Number (RIN) Compliance System,” which would allow for year-round use of gasoline blended with up to 15 percent ethanol.

Influential CEO Jamie Dimon to Deliver Keynote at BIO 2019

Apr 29 2019
The Biotechnology Innovation Organization (BIO) today announced that Chairman and CEO of JPMorgan Chase & Co., Jamie Dimon – a leader in the banking industry and catalyst for innovation across American business, including the healthcare industry– will headline a keynote address at the 2019 BIO International Convention, the world’s premier life sciences event being held in Philadelphia, June 3-6.

BIO Applauds Bipartisan Congressional Letters Supporting Funding of Farm Bill Energy Programs

Apr 17 2019
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood today applauded a Senate letter authored by Senator Tina Smith (D-Minn.) and a House letter authored by Representatives Angie Craig (D-Minn.) and Mike Bost (R-Ill.) expressing support for funding Farm Bill energy programs in Fiscal Year 2020 appropriations.

Biotechnology Industry Takes Action To Diversify Leadership

Apr 16 2019
The Biotechnology Innovation Organization (BIO) announced today the “Right Mix Matters” campaign to increase diversity and inclusion in the biotech industry. Following on its previously announced goals to increase gender, racial, ethnic and LGBTQ representation on biotech company boards, in C-suites and in functional leadership positions, BIO is providing specific tools to accelerate diversity and thereby advance an even more globally competitive industry. 

New Drug Cost Poll Shows Top Concern for Voters is Lowering Out-of-Pocket Costs

Apr 3 2019
As policymakers continue to examine ways to make prescription drugs more affordable, the Biotechnology Innovation Organization (BIO), in conjunction with Morning Consult, has released new polling data that show voters’ views on prescription drug costs. Results will be shared with Washington D.C. lawmakers today as BIO hosts its annual fly-in on Capitol Hill.

Senator Roberts Presented Lifetime Achievement Award

Apr 3 2019

Washington, D.C. (April 3, 2019) – The Biotechnology Innovation Organization (BIO) today announced Senator Pat Roberts (R-KS) will be presented with a Lifetime Achievement Award. Senator Roberts...

Siddhartha Mukherjee, author of “The Emperor of All Maladies: A Biography of Cancer” to Open on Keynote Stage at BIO 2019

Mar 28 2019
Pulitzer Prize-winning author, physician and oncologist, Siddhartha Mukherjee with headline BIO 2019 in a keynote speach on Tuesday, June 4.  He is the author of The Emperor of All Maladies: A Biography of Cancer, and the New York Times Best Seller, The Gene: An Intimate History.

BIO Applauds Bipartisan Senate Letter on U.S.-China Trade Negotiations

Mar 14 2019
BIO President and CEO Jim Greenwood today applauded a letter authored by Senators Pat Roberts (R-Kan.) and Debbie Stabenow (D-Mich.) to President Trump urging him to continue prioritizing in U.S.-China trade negotiations the need for China to commit to systemic change and implement a predictable, timely, transparent, and science-based biotech crop approval process.